To chase, follow or take legal action against someone or something etc in order to catch them, attack them or to get a legal remedy etc.
Founder | Patent Attorney | Business Leader
6 years of experience
Intellectual Property, Business Law, Trademarks, Patents, Energy, Oil & Gas Law, Communications & Internet Law, Gov & Administrative Law, Appeals & Appellate
Tennessee
Kevin Christopher is the founder and principal of Rockridge Venture Law®, Tennessee’s only B Corp Best For The World law firm. Kevin is a registered patent attorney, entrepreneur, county and state commissioner, National Institutes of Health (NIH) RadX faculty member, and National Science Foundation (NSF) program evaluator. He is a Leadership Lawyer and Leadership Tennessee alumnus, and board member to several environmental and social impact nonprofits. Kevin has been recognized as a SuperLawyer by Thomson Reuters and Top Business Leader by Conscious Company Magazine. Attorney Kevin Christopher is a corporate attorney, patent attorney, and trademark attorney. Specifically, his practice areas include: patent and trademark prosecution, licensing and litigation; corporate law, with an emphasis on benefit corporations, socially responsible businesses and high-growth emergent companies; government contracts, with an emphasis on innovation funding; corporate and investor financing; and, technology commercialization. In addition to his corporate practice Kevin helps many entrepreneurs as program advisor with AgLaunch, Bethesda Green Hub, CoLab, Nashville Entrepreneur Center, and Singularity University Ventures. Prior to founding RVL®, Attorney Kevin Christopher led bioscience and biotech development activities with top secret security clearance at Lawrence Livermore National Lab. His copyright and patent licensing portfolio included anti-infectives, drug delivery systems, neural interface devices, sequencing software, and other state of the art technologies. Kevin’s commercialization of a microbiome analysis chip resulted in in a Federal Licensing Consortium deal of the year award. Kevin managed a 40+ patent neural interface portfolio that was licensed as the groundbreaking Argus II artificial retina, and additionally directed to multi-region neuron mapping and as a tool for the treatment of traumatic brain injury (TBI). View More ›
Free Consultation I offer a free, scheduled assessment of how I can help you.
English: Spoken, Written
other | Biomedical Engineering Graduate Group
other | Energy, Law
J.D. (2010)
Visiting Student
Member
Current
Member, Executive Council
2017 - Current
Member, Class of 2017
2017 - Current
Advisory Board Member
2016 - Current
Advisory Board Member
2016 - Current